Page last updated: 2024-10-17

3,4-dihydroxyphenylacetic acid and Acquired-Immune Deficiency Syndrome Dementia Complex

3,4-dihydroxyphenylacetic acid has been researched along with Acquired-Immune Deficiency Syndrome Dementia Complex in 1 studies

3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Meulendyke, KA1
Pletnikov, MV1
Engle, EL1
Tarwater, PM1
Graham, DR1
Zink, MC1

Other Studies

1 other study available for 3,4-dihydroxyphenylacetic acid and Acquired-Immune Deficiency Syndrome Dementia Complex

ArticleYear
Early minocycline treatment prevents a decrease in striatal dopamine in an SIV model of HIV-associated neurological disease.
    Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 2012, Volume: 7, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; AIDS Dementia Complex; Animals; Blotting, Western; Chromatography, H

2012